← back to search

Eric Karran

KU Leuven · BE
Area of research
Physiology · Pharmacology
Research interest
Research interests include Disease, Neuroscience, Neurodegeneration, Biology, Alzheimer's disease, and Medicine.
h-index
citations
6,435
works
10
NIH funding
primary concept
email

Recent publications

Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial
Alzheimer s & Dementia 2025cited by 1position: middledoi
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
Cell Reports 2019cited by 965position: middledoi
Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing
Nature Communications 2019cited by 130position: middledoi
Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
Alzheimer s Research & Therapy 2019cited by 34position: middledoi
Precision pharmacology for Alzheimer’s disease
Pharmacological Research 2018cited by 104position: middledoi
The Cellular Phase of Alzheimer’s Disease
Cell 2016cited by 1,924position: lastdoi
The amyloid cascade hypothesis: are we poised for success or failure?
Journal of Neurochemistry 2016cited by 396position: firstdoi
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
Molecular Psychiatry 2013cited by 440position: middledoi
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Nature Neuroscience 2012cited by 1,942position: middledoi
The mechanism of γ‐Secretase dysfunction in familial Alzheimer disease
The EMBO Journal 2012cited by 499position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bart De Strooper · The Francis Crick Institute5 papers (2012–2019)Iryna Benilova · KU Leuven2 papers (2012–2012)Jens Wiltfang · Johannes Gutenberg University Mainz1 papers (2012–2012) · 1 papers (2018–2018)David C. Rubinsztein · UK Dementia Research Institute1 papers (2019–2019)Frédéric Rousseau · VIB-KU Leuven Center for Cancer Biology1 papers (2012–2012)Miguel A. Esteban · Medizinische Hochschule Hannover1 papers (2019–2019)Andrew Bassett · Wellcome Sanger Institute1 papers (2019–2019)Eloïse Hudry · Novartis (Switzerland)1 papers (2019–2019)Benjamin R. Underwood · Cambridge University Hospitals NHS Foundation Trust1 papers (2025–2025)Iryna Voytyuk · University of Cambridge1 papers (2019–2019) · 1 papers (2025–2025)María Jiménez-Sánchez · King's College London1 papers (2019–2019) · 1 papers (2018–2018)Hugo J. R. Fernandes · UK Dementia Research Institute1 papers (2019–2019)Gyan Srivastava · University of Missouri1 papers (2019–2019)Lutgarde Serneels · Vlaams Instituut voor Biotechnologie1 papers (2012–2012)Takaomi C. Saido · Keio University1 papers (2019–2019)Lucía Chávez‐Gutiérrez · Allen Institute for Brain Science1 papers (2012–2012)Sam Lismont · KU Leuven1 papers (2012–2012)